Джозеф Меркола - Кето-диета. Революционная система питания, которая поможет похудеть и «научит» ваш организм превращать жиры в энергию

41. “Migraine Statistics,” Migraine.com, https://migraine.com/migraine-statistics/, accessed November 28, 2016.

42. PubMed.gov, https://www.ncbi.nlm.nih.gov/pubmed/?term=migraine+food-i-allergy, accessed November 28, 2016.

43. K. Alpay et al., “Diet Restriction in Migraine, Based on IgG Against Foods: A Clinical Double-blind, Randomised, Cross-over Trial,” Cephalalgia , 30, no. 7 (2010): 829–837, DOI: 10.1177/0333102410361404.

44. C. Di Lorenzo et al., “Migraine Improvement During Short Lasting Ketogene-sis: A Proof-of-Concept Study,” European Journal of Neurology, 22, no. 1 (2015): 170–177, DOI: 10.1111/ene.l2550.

45. C. Di Lorenzo et al., “Diet Transiently Improves Migraine in Two Twin Sisters: Possible Role of Ketogenesis?” Functional Neurology , 28, no. 4 (2013): 305–308.

46. K. L. Munger et al., “Vitamin D Intake and Incidence of Multiple Sclerosis,” Neurology, 62, no. 1, (2004): 60–65, PMID: 14718698.

47. D. Y. Kim et al., “Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis,” PLoS One, 7, no. 5 (2012): e35476, DOI: 10.1371/journal.pone.0035476.

48. M. Storoni and G. T. Plant, “The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis,” Multiple Sclerosis International, 2015 (2015): 681289, DOI: 10.1155/2015/681289.

49. Там же.

50. “Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liv-erfoundation.org/abouttheliver/info/nafld/, accessed November 28, 2016.

51. S. S. Sundaram, “Pediatric Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liverfoundation.org/chapters/rockymountain/doctorsnotes/ pediatricnafld/, accessed November 28, 2016.

52. J. Ma et al., “Sugar-sweetened Beverage, Diet Soda, and Fatty Liver Disease in the Framingham Heart Study Cohorts,” Journal of Hepatology, 63, no. 2 (2015): 462–469, DOI: 10.1016/j.jhep.2015.03.032.

53. J. D. Browning et al., “Short-term Weight Loss and Hepatic Triglyceride Reduction: Evidence of a Metabolic Advantage with Dietary Carbohydrate Restriction,” The American Journal of Clinical Nutrition, 93, no. 5 (2011): 1048–1052. DOI: 10.3945/ajcn.l 10.007674.

54. J. Perez-Guisado and A. Munoz-Serrano, “The Effect of the Spanish Ketogenic Mediterranean Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Journal of Medicinal Food, 14, no. 7–8 (July-August 2011): 677–680, DOI: 10.1089/ jmf.2011.0075.

55. D. Tendler et al., “The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Digestive Diseases and Sciences , 52, no. 2 (February, 2007): 589–593, DOI: 10.1007/sl0620-006-9433-5.

56. P. Kennedy, “The Fat Drug.” The New York Times, March 8, 2014, http://www.ny-times.com/2014/03/09/opinion/sunday/the-fat-drug.html?_r=0, accessed 12/2/16.

57. H.-Y. Kim et al., “Phosphatidylserine-dependent Neuroprotective Signaling Promoted by Docosahexaenoic Acid,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, 82, no. 4–6 (2010): 165–172, DOI: 10.1016/j.plefa.2010.02.025.

58. H.-Y. Kim et al., “N-Docosahexaenoylethanolamide Promotes Development of Hippocampal Neurons,” The Biochemical Journal, 435, no. 2 (2011): 327–336, DOI: 10.1042/BJ20102118.

59. R. Palacios-Pelaez, W. J. Lukiw, and N. G. Bazan, “Omega-3 Essential Fatty Acids Modulate Initiation and Progression of Neurodegenerative Disease,” Molecular Neurobiology, 41, no. 2–3 (June 2010): 367–374, DOI: 10.1007/sl2035-010-8139-z.

60. Interview with J. J. Virgin, http://articles.mercola.com/sites/articles/ar-chive/2014/02/09/fish-oil-brain-health.aspx, accessed 12/2/16.

61. S. Smith, “Fish Oil Helped Save Our Son,” CNN, http://www.cnn.com/2012/10/19/ health/fish-oil-brain-injuries/index.html, accessed 12/2/16.

62. M. L. Prins and J. H. Matsumoto, “The Collective Therapeutic Potentialof Cerebral Ketone Metabolism in Traumatic Brain Injury,” Journal of Lipid Research, 55, no. 12 (2014): 2450–2457, DOI: 10.1194/jlr.R046706.

63. H. Algattas and J. H. Huang, “Traumatic Brain Injury Pathophysiology and Treatments: Early, Intermediate, and Late Phases Post-Injury,” International Journal of Molecular Sciences, 15, no. 1 (2014): 309–341, DOI: 10.3390/ijmsl5010309.

64. Там же.

65. M. L. Prins, L. S. Fujima, and D. A. Hovda, “Age-dependent Reduction of Cortical Contusion Volume by Ketones After Traumatic Brain Injury,” Journal of Neuroscience Research, 82, no. 3 (November 1, 2005): 413–420, DOI: 10.1002/jnr.20633.

66. Z. G. Hu et al., “The Protective Effect of the Ketogenic Diet on Traumatic Brain Injury-Induced Cell Death in Juvenile Rats,” Brain Injury, 23, no. 5 (2009): 459–465, DOI: 10.1080/02699050902788469.

67. “National Diabetes Statistics Report, 2014,” National Center for Chronic Disease Prevention and Health Promotion, http://www.cdc.gov/diabetes/pubs/statsre-portl4/national-diabetes-report-web.pdf, accessed 12/2/16.

68. “Diabetes Facts and Figures,” International Diabetes Foundation, http://www.idf. org/about-diabetes/facts-figures, accessed November 28, 2016.

69. D. Dabelea et al., “Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009,” Journal of the American Medical Association, 311, no. 17 (2014): 1778–1786, DOI: 10.1001/jama.2014.3201.

70. S. Vijan et al., “Effect of Patients’ Risks and Preferences on Health Gains with Glucose Lowering in Type 2 Diabetes,” JAMA Internal Medicine, 174, no. 8 (2014): 1227–1234, DOI: 10.1001/jamainternmed.2014.2894.

71. M. M. Poplawski et al., “Reversal of Diabetic Nephropathy by a Ketogenic Diet,” PLoS One , 6, no. 4 (2011): el8604, DOI: 10.1371/journal.pone.0018604.

72. R. D. Feinman et al., “Dietary Carbohydrate Restriction as the First Approach in Diabetes Management: Critical Review and Evidence Base,” Nutrition, 31, no. 1 (2015): 1-13, DOI: 10.1016/j.nut.2014.06.01.1.

73. “Making Healthy Food Choices: Grains and Starchy Vegetables,” American Diabetes Association, http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/ making-healthy-food-choices/grains-and-starchy-vegetables.html, accessed November 28, 2016.

1. M. S. Touillaud et al., “Dietary Lignan Intake and Postmenopausal Breast Cancer Risk by Estrogen and Progesterone Receptor Status,” Journal of the National Cancer Institute, 2007, 99(6): 475–486, DOI: 10.1093/jnci/djk096.

2. A. Ahmad et al., “A Review on Therapeutic Potential of Nigella Sativa: A Miracle Herb,” Asian Pacific Journal of Tropical Biomedicine, 2013, 3(5): 337–352, DOI: 1016/S2221-1691(13)60075-1.

3. S. Hasani-Ranjbar, Z. Jouyandeh, and M. A. Abdollahi, “A Systematic Review of Anti-Obesity Medicinal Plants – An Update,” Journal of Diabetes and Metabolic Disorders, 2013, 12:28, DOI: 10.1186/2251-6581-12-28.

4. M. Yadav et al., ’’Medicinal and biological Potential of Pumpkin: An Updated Review,” Nutrition Research Reviews, 2010, 23(2), 184–190, DOI: 10.1017/ S0954422410000107.

5. W. A. Morgan and B. J. Clayshulte, “Pecans Lower Low Density Lipoprotein Cholesterol in People with Normal Lipid Levels,” Journal of the American Dietetic Association, March 2000, 100(3): 312–318, DOI: 10.1016/S0002-8223(00)00097-3.

6 Oakridge Associated Universities, “Brazil Nuts,” http://www.orau.org/PTP/collec-tion/consumer%20products/brazilnuts.htm.